Defence Therapeutics is at the forefront of biopharmaceutical innovation, primarily through its proprietary Accum™ Technology, which significantly enhances drug delivery systems. This patented platform boasts a tenfold increase in the effectiveness of antibody-drug conjugates (ADCs) against infected cells compared to existing solutions. By focusing on precise drug delivery to the nucleus of target cells, Accum™ addresses critical challenges in cancer treatment, such as drug resistance and non-specific toxicity. The technology allows for the accumulation of more ADCs within the target cells, effectively breaking through cell membranes and ensuring that therapeutic agents reach their intended sites, thereby improving therapeutic outcomes for both cancer and infectious diseases.

The Accum™ Technology not only enhances the efficacy of current ADCs but also serves as a scalable solution for future drug development, including vaccines. Defence Therapeutics aims to leverage this innovative platform to create proprietary vaccines and address unmet medical needs in oncology and infectious disease treatment. The company is committed to advancing its research through strategic partnerships and collaborations, showcasing its potential to revolutionize therapeutic standards in the healthcare industry. With a focus on overcoming previous limitations in drug delivery, Defence Therapeutics is positioned to make significant contributions to the treatment landscape for challenging diseases.

Canada

Defence Therapeutics is a publicly-traded (CSE: DTC, OTCQB: DTCFF, FSE: DTC) clinical-stage biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform. The core of Defence Therapeutics platform is the ACCUM® technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. As a result, increased efficacy and potency can be reached against catastrophic illness such as cancer and infectious
diseases.

Defence Therapeutics

Company Details